40 research outputs found
Pluripotent Stem Cells in Toxicity Testing: An Omics Approach
Traditional approaches to toxicological testing are expensive and time consuming usually involving exposure of chemicals to large numbers of animals during the crucial period of organ development. In order to provide cost-efficient and high-throughput methods, various in vitro test systems have been proposed to access toxicity for environmental toxicants and many drugs. Although effective, these platforms are based on in vitro cell cultures and ex vivo models using embryo cultures and often do not accurately interpret results for human safety because of interspecies difference and/or the inability to reproduce human physiology. To address this problem, a humanized system, pluripotent stem cells were introduced to study toxicity of drugs
Leptin receptor signaling regulates protein synthesis pathways and neuronal differentiation in pluripotent stem cells
The role of leptin receptor (OB-R) signaling in linking pluripotency with growth and development and the consequences of dysfunctional leptin signaling on progression of metabolic disease is poorly understood. Using a global unbiased proteomics approach we report that embryonic fibroblasts (MEFs) carrying the db/db mutation exhibit metabolic abnormalities, while their reprogrammed induced pluripotent stem cells (iPSCs) show altered expression of proteins involved in embryonic development. An upregulation in expression of eukaryotic translation initiation factor 4e (Eif4e) and Stat3 binding to the Eif4e promoter was supported by enhanced protein synthesis in mutant iPSCs. Directed differentiation of db/db iPSCs toward the neuronal lineage showed defects. Gene editing to correct the point mutation in db/db iPSCs using CRISPR-Cas9, restored expression of neuronal markers and protein synthesis while reversing the metabolic defects. These data imply a direct role for OB-R in regulating metabolism in embryonic fibroblasts and key developmental pathways in iPSCs.publishedVersio
Recommended from our members
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas
Meningiomas are the most common primary intracranial adult tumor. All Neurofibromatosis 2 (NF2)-associated meningiomas and ~60% of sporadic meningiomas show loss of NF2 tumor suppressor protein. There are no effective medical therapies for progressive and recurrent meningiomas. Our previous work demonstrated aberrant activation of mTORC1 signaling that led to ongoing clinical trials with rapamycin analogs for NF2 and sporadic meningioma patients. Here we performed a high-throughput kinome screen to identify kinases responsible for mTORC1 pathway activation in NF2-deficient meningioma cells. Among the emerging top candidates were the mTORC2-specific target serum/glucocorticoid-regulated kinase 1 (SGK1) and p21-activated kinase 1 (PAK1). In NF2-deficient meningioma cells, inhibition of SGK1 rescues mTORC1 activation, and SGK1 activation is sensitive to dual mTORC1/2 inhibitor AZD2014, but not to rapamycin. PAK1 inhibition also leads to attenuated mTORC1 but not mTORC2 signaling, suggesting that mTORC2/SGK1 and Rac1/PAK1 pathways are independently responsible for mTORC1 activation in NF2-deficient meningiomas. Using CRISPR-Cas9 genome editing, we generated isogenic human arachnoidal cell lines (ACs), the origin cell type for meningiomas, expressing or lacking NF2. NF2-null CRISPR ACs recapitulate the signaling of NF2-deficient meningioma cells. Interestingly, we observe increased SGK1 transcription and protein expression in NF2-CRISPR ACs and in primary NF2-negative meningioma lines. Moreover, we demonstrate that the dual mTORC1/mTORC2 inhibitor, AZD2014 is superior to rapamycin and PAK inhibitor FRAX597 in blocking proliferation of meningioma cells. Importantly, AZD2014 is currently in use in several clinical trials of cancer. Therefore, we believe that AZD2014 may provide therapeutic advantage over rapalogs for recurrent and progressive meningiomas
Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
Propensity of murine embryonic stem cell differentiation in presence of Fam40b RNAi and chemopreventive agents
International Technological Conference-2014 (I-TechCON)
ABSTRACT Human tracking is a comprehensive framework for tracking coarse human model performed from sequences of synchronized monocular grayscale images in single or multiple camera system coordinates. It is nothing but segmenting an interested human from video scene and keep track if it continuously. It demonstrates the feasibility of an end to end person tracking system where initially it start background subtraction, then detection of the interested human and tracking of that human form one frame to another continuously. For detection of the interested human PCA algorithm is used. Finally Kalman filter is introduced into tracking the people. Our system have demonstrated that as compaired with other methods it reduces detection time comparitively and improves human detection and tracking accuracy
Propensity of murine embryonic stem cell differentiation in presence of Fam40b RNAi and chemopreventive agents
Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10Â years survival
Abstract Aims Mechanochemical signalling drives organogenesis and is highly conserved in mammal evolution. Regaining recovery in myocardial jeopardy by inducing principles linking cardiovascular therapy and clinical outcome has been the dream of scientists for decades. Concepts involving embryonic pathways to regenerate adult failing hearts became popular in the early millennium. Since then, abundant data on stem cell research have been published, never reaching widespread application in heart failure therapy. Another conceptual access, using mechanotransduction in cardiac veins to limit myocardial decay, is pressureâcontrolled intermittent coronary sinus occlusion (PICSO). Recently, we reported acute molecular signs and signals of PICSO activating regulatory miRNA and inducing cell proliferation mimicking cardiac development in adult failing hearts. According to a previously formulated hypothesis, âembryonic recallâ, this study aimed to define molecular signals involved in endogenous heart repair during PICSO and study their relation to patient survival. Methods and results We previously reported a study on the acute molecular effects of PICSO in an observational nonârandomized study. Eight out of the thirtyâtwo patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT) were treated with PICSO. Survival was monitored over 10 years, and coronary sinus blood samples were collected during intervention before and after 20 min and tested for miRNA signalling and proliferation when coâcultured with cardiomyocytes. A numerically lower death rate postâCRT and PICSO as compared with control CRT only, and a nonâsignificant reduction in allâcause mortality risk of 42% was observed (37.5% vs. 54.0%, relative risk = 0.58, 95% confidence interval: 0.17â2.05; P = 0.402). Four miRNAs involved in cell cycle, proliferation, morphogenesis, embryonic development, and apoptosis significantly increased concomitantly in survivors and PICSO compared with a decrease in nonâsurvivors (hsaâmiR Let7b, P < 0.01; hsaâmiRâ 421, P < 0.006; hsaâmiR 363â3p, P < 0.03 and hsaâmiR 19bâ3p P < 0.01). In contrast, three miRNAs involved in proliferation and survival, determining cell fate, and recycling endosomes decreased in survivors and PICSO (hsa miR 101â3p, P < 0.03; hsaâmiR 25â3p, P < 002; hsaâmiR 30dâ5p P < 0.04). In vitro cellular proliferation increased in survivors and lowered in nonâsurvivors showing a pattern distinction, discriminating longevity according to up to 10âyear survival in heart failure patients. Conclusions This study proposes that generating regenerative signals observed during PICSO intervention relate to patient outcomes. Morphogenetic pathways induced by periods of flow reversal in cardiac veins in a dominoâlike pattern transform embryonic into regenerative signals. Studies supporting the conversion of mechanochemical signals into regenerative molecules during PICSO are warranted to substantiate predictive power on patient longevity, opening new therapeutic avenues in otherwise untreatable heart failure
NPB001-05 Inhibits Bcr-Abl Kinase Leading to Apoptosis of Imatinib-Resistant Cells
The deregulated activity of the Bcr-Abl tyrosine
kinase provides a rational basis for the development
therapeutics in all phases of Chronic Myelogenous
Leukemia (CML). Although a well studied imatinib
therapy has clinical success against CML, resistance to
imatinib due to mutations in the kinase domain, especially
T315I poses a major problem for the ultimate success of
CML therapy by this agent. Herein we describe an
NPB001-05, derived from extract of Piper betle leafs,
which is highly active in specifically inhibiting Bcr-Abl
expressing cells. NPB001-05 inhibited the proliferation of
BaF3 cells ectopically expressing wild type Bcr-Abl
phenotype and 12 different imatinib-resistant mutations of
clinical relevance (average IC50 5.7 ÎŒg/ml). Moreover,
NPB001-05 was highly inhibitory to wild type P210Bcr-Abl
and P210Bcr-Abl-T315I kinase activity and abrogated the
autophosphorylating enzyme in time- and dose- dependent
manner. NPB001-05 was non-toxic on normal cells, but
was inhibitory to CML patient derived peripheral blood
mononuclear cells. Treatment with NPB001-05 caused
apoptosis induction and G0G1 cell cycle arrest in both Bcr-
Abl wild type and T315I mutant cell line
Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
Drug-induced off-target cardiotoxicity, particularly following anti-cancer therapy, is a major concern in new drug discovery and development. To ensure patient safety and efficient pharmaceutical drug development, there is an urgent need to develop more predictive cell model systems and distinct toxicity signatures. In this study, we applied our previously proposed repeated exposure toxicity methodology and performed H-1 NMR spectroscopy-based extracellular metabolic profiling in culture medium of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exposed to doxorubicin (DOX), an anti-cancer agent. Single exposure to DOX did not show alteration in the basal level of extracellular metabolites while repeated exposure to DOX caused reduction in the utilization of pyruvate and acetate, and accumulation of formate compared to control culture medium. During drug washout, only pyruvate showed reversible effect and restored its utilization by hiPSC-CMs. On the other hand, formate and acetate showed irreversible effect in response to DOX exposure. DOX repeated exposure increased release of lactate dehydrogenase (LDH) in culture medium suggesting cytotoxicity events, while declined ATP levels in hiPSC-CMs. Our data suggests DOX perturbed mitochondrial metabolism in hiPSC-CMs. Pyruvate, acetate and formate can be used as metabolite signatures of DOX induced cardiotoxicity. Moreover, the hiPSC-CMs model system coupled with metabolomics technology offers a novel and powerful approach to strengthen cardiac safety assessment during new drug discovery and development